Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 11Lung Neoplasms 6Colonic Neoplasms 5Pancreatic Neoplasms 3Pain, Postoperative 3Inflammatory Bowel Diseases 3Diverticulitis 3Carcinoma, Hepatocellular 3Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Leiomyoma 2Inflammation 2Carcinoma, Non-Small-Cell Lung 2Abdominal Cancer 2Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Neoplasms 1Stomatitis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Skin Neoplasms 1Shoulder Pain 1Respiration Disorders 1Psychological Well-Being 1Postoperative Complications 1Post-thoracotomy Pain Syndrome 1Neoplasms 1Mouth Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Vaccines, Synthetic 10Papillomavirus Vaccines 6Vaccines 5Imiquimod 4Trichloroacetic Acid 3Gels 3green tea extract polyphenone E 2Podophyllin 2Human Papillomavirus Recombinant Vaccine nonavalent 2Ethanol 2Duration of Therapy 2Cryotherapy 2Cantharidin 2ranpirnase 1polyphenon E 1nanocurcumin 1human papillomavirus vaccine, L1 type 16, 18 1hecolin 1berdazimer sodium 1Zinc 1Viusid 1Vaccination 1VP-102 1Tuberculin 1Therapies, Investigational 1Tea 1PRA1 protein, Candida albicans 1Omiganan 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Condylomata Acuminata × Tea × Clear all
NCT01490008 2012-04-19

Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers

MediGene

Phase 1 Completed
30 enrolled

Condylomata Acuminata

Data powered by HemOnc (CC BY 4.0) Colophon âš¡